Mankind Pharma Profit Jumps 39 Percent
Mankind Pharma posted a 39 percent rise in quarterly profit to 7.11 billion rupees on Monday. Strong demand for chronic therapies like diabetes and cardiac treatments drove the domestic revenue growth.
Xurve View
Insights:
Xurve View
Mankind Pharma posted a 39% jump in second-quarter profit to 7.11 billion rupees ($74.7 million), driven by robust chronic drug demand in India on Monday. This performance outpaces domestic rivals facing rising research costs. The results highlight strong physician adoption of domestic formulations across high-margin therapeutic segments.
